80 related articles for article (PubMed ID: 22584348)
21. [Clinical role of F-18 FDG PET/CT in differentiating malignant and benign pleural effusion in patients with lung cancer].
Liao R; Yang X; Wang S; Zhou Q; Nie Q; Zhong W; Dong S; Wu Y
Zhongguo Fei Ai Za Zhi; 2012 Nov; 15(11):652-5. PubMed ID: 23164351
[TBL] [Abstract][Full Text] [Related]
22. Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion.
Gupta NC; Rogers JS; Graeber GM; Gregory JL; Waheed U; Mullet D; Atkins M
Chest; 2002 Dec; 122(6):1918-24. PubMed ID: 12475827
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.
Nakajima R; Abe K; Sakai S
Medicine (Baltimore); 2015 Jul; 94(29):e1010. PubMed ID: 26200610
[TBL] [Abstract][Full Text] [Related]
24. Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis.
Fjaellegaard K; Koefod Petersen J; Reuter S; Malene Fischer B; Gerke O; Porcel JM; Frost Clementsen P; Laursen CB; Bhatnagar R; Bodtger U
Lung Cancer; 2021 Dec; 162():106-118. PubMed ID: 34775214
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
Porcel JM; Hernández P; Martínez-Alonso M; Bielsa S; Salud A
Chest; 2015 Feb; 147(2):502-512. PubMed ID: 25188411
[TBL] [Abstract][Full Text] [Related]
26. [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes].
Buchmann I; Guhlmann CA; Elsner K; Gfrörer W; Schirrmeister H; Kotzerke J; Buck A; Reske SN
Nuklearmedizin; 1999; 38(8):319-22. PubMed ID: 10615665
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
Duysinx B; Nguyen D; Louis R; Cataldo D; Belhocine T; Bartsch P; Bury T
Chest; 2004 Feb; 125(2):489-93. PubMed ID: 14769729
[TBL] [Abstract][Full Text] [Related]
28. Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography.
Toaff JS; Metser U; Gottfried M; Gur O; Deeb ME; Lievshitz G; Mercer D; Even-Sapir E
Invest Radiol; 2005 Apr; 40(4):204-9. PubMed ID: 15770138
[TBL] [Abstract][Full Text] [Related]
29. PET for the evaluation of pleural thickening observed on CT.
Kramer H; Pieterman RM; Slebos DJ; Timens W; Vaalburg W; Koëter GH; Groen HJ
J Nucl Med; 2004 Jun; 45(6):995-8. PubMed ID: 15181135
[TBL] [Abstract][Full Text] [Related]
30. Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions.
Porcel JM; Pardina M; Bielsa S; González A; Light RW
Chest; 2015 Feb; 147(2):513-519. PubMed ID: 25255186
[TBL] [Abstract][Full Text] [Related]
31. The contribution of PET/CT to the differentiation of benign and malignant pleural effusion in patients with ovarian carcinoma.
Budak A; Yanarateş A; Budak E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):353-358. PubMed ID: 37172933
[TBL] [Abstract][Full Text] [Related]
32. Thoracic computed tomography in patients with suspected malignant pleural effusions.
Traill ZC; Davies RJ; Gleeson FV
Clin Radiol; 2001 Mar; 56(3):193-6. PubMed ID: 11247695
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis of pleural effusion in intensive care patients with supine digital thoracic imaging. A study of CT validated cases].
Schäfer C; Sokiranski R; Bartzsch OM; Riedl W
Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Feb; 32(2):109-14. PubMed ID: 9172714
[TBL] [Abstract][Full Text] [Related]
34. Pleural Uptake Patterns in
Cohen SE; Betancourt J; Soo Hoo GW
J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002592
[TBL] [Abstract][Full Text] [Related]
35. Derivation and validation of a 18F-FDG PET/CT scoring model to predict malignant pleural effusion.
Lu P; Sun Y; Liang B; Yu L
Nucl Med Commun; 2022 Feb; 43(2):177-185. PubMed ID: 34864810
[TBL] [Abstract][Full Text] [Related]
36. Atypical Layering of FDG in Pleural Effusion.
Han EJ; Yoon H; Choi WH
Clin Nucl Med; 2024 Feb; 49(2):162-165. PubMed ID: 37976534
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic diagnosis of malignant pleural effusions: culture methods to supplement direct preparations in diagnosis.
Dewald GW; Hicks GA; Dines DE; Gordon H
Mayo Clin Proc; 1982 Aug; 57(8):488-94. PubMed ID: 6954335
[TBL] [Abstract][Full Text] [Related]
38. [Changes in myeloid-derived suppressor cells in malignant effusions of cancer patients following cancer chemotherapy].
Gonda K; Shibata M; Shimura T; Abe N; Suzuki S; Yasuda M; Nakamura I; Ohtake T; Ohki S; Watanabe T; Fujimori K; Suzuki S; Ohto H; Takenoshita S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2088-91. PubMed ID: 23267986
[TBL] [Abstract][Full Text] [Related]
39. CAMPO Precision128 Max ENERGY Spectrum CT Combined with Multiple Parameters to Evaluate the Benign and Malignant Pleural Effusion.
Zhang T; Wu C; Li Z; Ding Y; Wen L; Wang L
J Healthc Eng; 2021; 2021():5526977. PubMed ID: 33728032
[TBL] [Abstract][Full Text] [Related]
40. Computerized tomography pleurography: a new method for detecting minor pleural lesion.
Gong R; Wu L
Chin Med J (Engl); 2001 Sep; 114(9):937-40. PubMed ID: 11780386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
